Toronto firm buys operator of US medical marijuana ‘evaluation centers’

A Toronto company billing itself as the “WebMD of medical cannabis” has acquired Massachusetts-based Canna Care Docs, which certifies MMJ patients in 21 “evaluation centers” across nine states.

Sail Cannabis funded the Canna Care acquisition with proceeds from a brokered private placement led by Canaccord Genuity worth about 4 million Canadian dollars ($3.2 million), Sail CEO Pradyum Sekar told Marijuana Business Daily.

Financial terms of the acquisition were not disclosed.

Sekar described Sail’s community platform as the “WebMD of medical cannabis” but added, “we also have tools on top of that so you’re not just reading information – you can book appointments, communicate with other members.

“Physicians can also use the system to run their clinics and manage care of their patients.”

He said Sail’s software uses “clinically data-driven tools” to help determine the right strain, product, dosing and methodology.

In Canada, the platform is currently being used in over 40 cannabis clinics and by primary care physicians.

Sail has been operating in Canada since 2016 as a private company and has seen over 30,000 patient encounters, according to a news release.

Canna Care uses the Sail platform and has certified over 250,000 patients for medical cannabis.

To sign up for our weekly Canada marijuana business newsletter, click here.
One comment on “Toronto firm buys operator of US medical marijuana ‘evaluation centers’

Leave a Reply

Your email address will not be published. Required fields are marked *